BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12931338)

  • 1. A little learning is a dangerous thing; especially for a cytotoxic T-lymphocyte.
    Griffiths PD
    Rev Med Virol; 2003; 13(5):275-6. PubMed ID: 12931338
    [No Abstract]   [Full Text] [Related]  

  • 2. Destructive networks in AIDS.
    Kennedy JR
    Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD4 T cell help for CD8 CTL activation.
    Zhang S; Zhang H; Zhao J
    Biochem Biophys Res Commun; 2009 Jul; 384(4):405-8. PubMed ID: 19410556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune balance in the cytomegalovirus-infected host: in vitro studies of virus-lymphocyte interactions and the effects on specific lymphocyte function.
    Casali P; Rice GP; Oldstone MB
    Birth Defects Orig Artic Ser; 1984; 20(1):149-59. PubMed ID: 6329358
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
    Liu J; Roederer M
    Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.
    Tsegaye A; Ran L; Wolday D; Petros B; Nanlohy NM; Meles H; Girma M; Hailu E; Borghans J; Miedema F; van Baarle D
    AIDS; 2007 Jan; 21(3):369-72. PubMed ID: 17255746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic CD4 T cells in viral hepatitis.
    Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
    J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
    Masopust D
    J Intern Med; 2009 Jan; 265(1):125-37. PubMed ID: 19093965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
    Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
    Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of immunopathogenic mechanisms of HIV infection.
    Feller L; Lemmer J
    SADJ; 2007 Nov; 62(10):432-4, 436. PubMed ID: 18500104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy.
    Fernandez S; Stone SF; Price P; French MA
    Clin Immunol; 2008 Aug; 128(2):228-37. PubMed ID: 18511344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
    Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
    Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.
    Bronke C; Jansen CA; Westerlaken GH; De Cuyper IM; Miedema F; Tesselaar K; van Baarle D
    Clin Immunol; 2007 Aug; 124(2):190-9. PubMed ID: 17556025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiological role of cytotoxic CD4(+) T-cells: the holy grail?
    Appay V
    Clin Exp Immunol; 2004 Oct; 138(1):10-3. PubMed ID: 15373899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.